The9 Says RF Acquisition Corp II Shareholders Approved Business Combination With Nanyang Biologics On August 19; Expects To Hold About 15% To 16% Of Combined Nasdaq-Listed Company

Loading news article.

The9 Says RF Acquisition Corp II Shareholders Approved Business Combination With Nanyang Biologics On August 19; Expects To Hold About 15% To 16% Of Combined Nasdaq-Listed Company | WAPE

The9 Says RF Acquisition Corp II Shareholders Approved Business Combination With Nanyang Biologics On August 19; Expects To Hold About 15% To 16% Of Combined Nasdaq-Listed Company

Article summary

Related companies

Analyzed by WAPE AI.

Comments —